Sign in
  1. Home
  2. Companies
  3. Stock VYNE Therapeutics
VYNE Therapeutics logo

VYNE Therapeutics VYNE

report update icon

Quarterly report 2026-Q2
added 08-13-2026

Country

 usaUSA

IPO year

 2018

Industry

 -

Stock Exchange

 NASDAQ GLOBAL

Shares

 42.8 M

Market Cap[1]

 $ 1.22 B

EBITDA (LTM)

 $ -3.81 M

P/E (LTM)

 -

P/S (LTM)

 14202.954419

EPS (LTM)

 -0.08

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.